Alignment Healthcare (NASDAQ:ALHC) President Dawn Christine Maroney Sells 282,070 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 282,070 shares of the firm’s stock in a transaction dated Monday, December 29th. The shares were sold at an average price of $18.74, for a total value of $5,285,991.80. Following the transaction, the president owned 1,385,167 shares of the company’s stock, valued at $25,958,029.58. This trade represents a 16.92% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Dawn Christine Maroney also recently made the following trade(s):

• On Monday, December 15th, Dawn Christine Maroney sold 113,319 shares of Alignment Healthcare stock. The stock was sold at an average price of $20.01, for a total transaction of $2,267,513.19.
• On Friday, December 12th, Dawn Christine Maroney sold 16,681 shares of Alignment Healthcare stock. The shares were sold at an average price of $20.02, for a total transaction of $333,953.62.

Alignment Healthcare Trading Up 1.6%

Shares of ALHC stock opened at $19.24 on Wednesday. The company has a debt-to-equity ratio of 1.99, a quick ratio of 1.61 and a current ratio of 1.61. The stock has a market capitalization of $3.85 billion, a P/E ratio of -160.33 and a beta of 1.16. The company has a 50 day moving average price of $18.22 and a 200 day moving average price of $16.22. Alignment Healthcare, Inc. has a fifty-two week low of $11.01 and a fifty-two week high of $21.06.

Alignment Healthcare (NASDAQ:ALHC) last released its earnings results on Thursday, October 30th. The company reported $0.02 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.03. Alignment Healthcare had a negative net margin of 0.57% and a negative return on equity of 16.23%. The company had revenue of $993.70 million for the quarter, compared to analyst estimates of $980.90 million. During the same period in the prior year, the business earned ($0.14) EPS. The firm’s quarterly revenue was up 43.5% on a year-over-year basis. Equities research analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Analyst Ratings Changes

ALHC has been the topic of a number of analyst reports. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $22.00 price target on shares of Alignment Healthcare in a research report on Monday, November 3rd. JPMorgan Chase & Co. upped their target price on shares of Alignment Healthcare from $20.00 to $23.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 17th. Zacks Research downgraded shares of Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 28th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Alignment Healthcare in a report on Wednesday, October 8th. Finally, Barclays raised their price objective on shares of Alignment Healthcare from $13.00 to $18.00 and gave the company an “equal weight” rating in a report on Friday, October 31st. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Alignment Healthcare has a consensus rating of “Moderate Buy” and an average target price of $20.35.

Hedge Funds Weigh In On Alignment Healthcare

Several hedge funds have recently added to or reduced their stakes in ALHC. Vanguard Group Inc. lifted its position in shares of Alignment Healthcare by 5.0% during the 3rd quarter. Vanguard Group Inc. now owns 13,968,584 shares of the company’s stock worth $243,752,000 after buying an additional 664,769 shares during the last quarter. Wellington Management Group LLP raised its stake in Alignment Healthcare by 167.3% during the 3rd quarter. Wellington Management Group LLP now owns 11,089,727 shares of the company’s stock worth $193,516,000 after acquiring an additional 6,940,277 shares in the last quarter. Hood River Capital Management LLC lifted its position in Alignment Healthcare by 6.0% in the second quarter. Hood River Capital Management LLC now owns 5,517,336 shares of the company’s stock valued at $77,243,000 after acquiring an additional 311,424 shares during the last quarter. 8 Knots Management LLC lifted its position in Alignment Healthcare by 6.4% in the second quarter. 8 Knots Management LLC now owns 5,015,881 shares of the company’s stock valued at $70,222,000 after acquiring an additional 300,409 shares during the last quarter. Finally, Invesco Ltd. boosted its stake in Alignment Healthcare by 7.1% in the third quarter. Invesco Ltd. now owns 4,466,630 shares of the company’s stock valued at $77,943,000 after acquiring an additional 296,101 shares in the last quarter. 86.19% of the stock is currently owned by hedge funds and other institutional investors.

Key Headlines Impacting Alignment Healthcare

Here are the key news stories impacting Alignment Healthcare this week:

• Positive Sentiment: Baird published a note saying Alignment Healthcare “should be bought on recent selloff,” which can attract value-oriented buyers and help lift the stock. Baird Buy Note
• Negative Sentiment: CEO John E. Kao sold 605,648 shares at an average price of $18.74 (~$11.35M), a 21.33% reduction in his holding — a large, high‑profile insider sale that can be read as a negative signal for sentiment. Kao SEC Filing
• Negative Sentiment: President Dawn Christine Maroney sold 282,070 shares at $18.74 (~$5.29M), cutting her stake by ~16.9% — another sizable insider disposition that can weigh on investor confidence. Maroney SEC Filing
• Negative Sentiment: Other insider sales include Robert L. Scavo (69,541 shares), Christopher J. Joyce (16,187 shares) and Hyong Kim (12,694 shares), each sold at $18.74 — smaller individually but collectively add to the sell-side signal. Scavo SEC Filing Joyce SEC Filing Kim SEC Filing

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.